Does TOFACITINIB Cause Osteomyelitis? 210 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 210 reports of Osteomyelitis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
210
Reports of Osteomyelitis with TOFACITINIB
0.1%
of all TOFACITINIB reports
9
Deaths
85
Hospitalizations
How Dangerous Is Osteomyelitis From TOFACITINIB?
Of the 210 reports, 9 (4.3%) resulted in death, 85 (40.5%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Osteomyelitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 210 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Osteomyelitis?
CANAGLIFLOZIN (2,146)
DENOSUMAB (701)
METHOTREXATE (673)
ADALIMUMAB (636)
ETANERCEPT (488)
ZOLEDRONIC ACID (419)
TOCILIZUMAB (400)
RITUXIMAB (360)
PREDNISONE (350)
LEFLUNOMIDE (332)
Which TOFACITINIB Alternatives Have Lower Osteomyelitis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN